Next Article in Journal
Fluorescence Recognition of Anions Using a Heteroditopic Receptor: Homogenous and Two-Phase Sensing
Next Article in Special Issue
Control of Expression of Key Cell Cycle Enzymes Drives Cell Line-Specific Functions of CDK7 in Human PDAC Cells
Previous Article in Journal
Bert Vallee—A 20th Century Adventure(r) in Zincology
Previous Article in Special Issue
BRAF and MEK Inhibitors Affect Dendritic-Cell Maturation and T-Cell Stimulation
Review

Structural Insights Support Targeting ASK1 Kinase for Therapeutic Interventions

1
Department of Structural Biology of Signaling Proteins, Division BIOCEV, Institute of Physiology of the Czech Academy of Sciences, 25250 Vestec, Czech Republic
2
Department of Physical and Macromolecular Chemistry, Faculty of Science, Charles University, 12843 Prague, Czech Republic
*
Authors to whom correspondence should be addressed.
Academic Editor: Atsushi Matsuzawa
Int. J. Mol. Sci. 2021, 22(24), 13395; https://doi.org/10.3390/ijms222413395
Received: 24 November 2021 / Revised: 10 December 2021 / Accepted: 11 December 2021 / Published: 13 December 2021
(This article belongs to the Special Issue Kinase Signal Transduction 3.0)
Apoptosis signal-regulating kinase (ASK) 1, a member of the mitogen-activated protein kinase kinase kinase (MAP3K) family, modulates diverse responses to oxidative and endoplasmic reticulum (ER) stress and calcium influx. As a crucial cellular stress sensor, ASK1 activates c-Jun N-terminal kinases (JNKs) and p38 MAPKs. Their excessive and sustained activation leads to cell death, inflammation and fibrosis in various tissues and is implicated in the development of many neurological disorders, such as Alzheimer’s, Parkinson’s and Huntington disease and amyotrophic lateral sclerosis, in addition to cardiovascular diseases, diabetes and cancer. However, currently available inhibitors of JNK and p38 kinases either lack efficacy or have undesirable side effects. Therefore, targeted inhibition of their upstream activator, ASK1, stands out as a promising therapeutic strategy for treating such severe pathological conditions. This review summarizes recent structural findings on ASK1 regulation and its role in various diseases, highlighting prospects for ASK1 inhibition in the treatment of these pathologies. View Full-Text
Keywords: ASK1; phosphorylation; MAP kinase; 14-3-3; kinase; protein–protein interaction ASK1; phosphorylation; MAP kinase; 14-3-3; kinase; protein–protein interaction
Show Figures

Figure 1

MDPI and ACS Style

Obsilova, V.; Honzejkova, K.; Obsil, T. Structural Insights Support Targeting ASK1 Kinase for Therapeutic Interventions. Int. J. Mol. Sci. 2021, 22, 13395. https://doi.org/10.3390/ijms222413395

AMA Style

Obsilova V, Honzejkova K, Obsil T. Structural Insights Support Targeting ASK1 Kinase for Therapeutic Interventions. International Journal of Molecular Sciences. 2021; 22(24):13395. https://doi.org/10.3390/ijms222413395

Chicago/Turabian Style

Obsilova, Veronika, Karolina Honzejkova, and Tomas Obsil. 2021. "Structural Insights Support Targeting ASK1 Kinase for Therapeutic Interventions" International Journal of Molecular Sciences 22, no. 24: 13395. https://doi.org/10.3390/ijms222413395

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop